Researchers at Keele University have said that more targeted use of testing for a common molecule could help to improve predictions of cardiovascular disease outcomes in patients at greatest risk.
Continue Reading
News Source: medicalxpress.com
Researchers at Keele University have said that more targeted use of testing for a common molecule could help to improve predictions of cardiovascular disease outcomes in patients at greatest risk.
News Source: medicalxpress.com
Leave a Reply